Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-05

Clinical Trial Update: ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED) [Phase 3]

View source ↗

Summary

This update notes that the ALBIOSS-BALANCED Phase 3 trial evaluating albumin therapy for septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Septic Shock | Phase 3 | Status: COMPLETED